×

News publications and other organizations are encouraged to reuse Direct Relief-published content for free under a Creative Commons License (Attribution-Non-Commercial-No Derivatives 4.0 International), given the republisher complies with the requirements identified below.

When republishing:

  • Include a byline with the reporter’s name and Direct Relief in the following format: "Author Name, Direct Relief." If attribution in that format is not possible, include the following language at the top of the story: "This story was originally published by Direct Relief."
  • If publishing online, please link to the original URL of the story.
  • Maintain any tagline at the bottom of the story.
  • With Direct Relief's permission, news publications can make changes such as localizing the content for a particular area, using a different headline, or shortening story text. To confirm edits are acceptable, please check with Direct Relief by clicking this link.
  • If new content is added to the original story — for example, a comment from a local official — a note with language to the effect of the following must be included: "Additional reporting by [reporter and organization]."
  • If republished stories are shared on social media, Direct Relief appreciates being tagged in the posts:
    • Twitter (@DirectRelief)
    • Facebook (@DirectRelief)
    • Instagram (@DirectRelief)

Republishing Images:

Unless stated otherwise, images shot by Direct Relief may be republished for non-commercial purposes with proper attribution, given the republisher complies with the requirements identified below.

  • Maintain correct caption information.
  • Credit the photographer and Direct Relief in the caption. For example: "First and Last Name / Direct Relief."
  • Do not digitally alter images.

Direct Relief often contracts with freelance photographers who usually, but not always, allow their work to be published by Direct Relief’s media partners. Contact Direct Relief for permission to use images in which Direct Relief is not credited in the caption by clicking here.

Other Requirements:

  • Do not state or imply that donations to any third-party organization support Direct Relief's work.
  • Republishers may not sell Direct Relief's content.
  • Direct Relief's work is prohibited from populating web pages designed to improve rankings on search engines or solely to gain revenue from network-based advertisements.
  • Advance permission is required to translate Direct Relief's stories into a language different from the original language of publication. To inquire, contact us here.
  • If Direct Relief requests a change to or removal of republished Direct Relief content from a site or on-air, the republisher must comply.

For any additional questions about republishing Direct Relief content, please email the team here.

Long-Range Drone Delivers Cold-Chain Medicines, Vaccines Between Islands in Caribbean

News

Central America and the Caribbean

Direct Relief, Merck, Softbox and Volans-i tested a program that would deliver cold-chain medicines via drone in case of disaster.(Photos courtesy of Merck)
By Staff

In what could represent a significant step forward in biopharmaceutical supply chain innovation and for humanitarian efforts around the world, a consortium comprised of AT&T, Direct Relief, Merck and Softbox has completed a program testing the potential of unmanned aerial vehicles (UAVs, also known as drones) to deliver temperature-dependent medicines and vaccines to hard-to-reach locations.

“Experience and research consistently show that those most at risk in disasters live in communities which are likely to be cut off from essential health care due to disruption of transportation and communications,” said Andrew Schroeder, director of research and analysis at Direct Relief. “Drone delivery is one of the most promising answers to this problem.”

In the test, a UAV flew over open water between the islands of the Bahamas, beyond the operator’s line of sight.

The fully autonomous flight incorporated cold-chain delivery technology allowing for precise control of temperatures as low as minus 70 Celsius, the level required for storing and transporting some life-saving medicines and vaccines. It utilized live, continuous temperature tracking through the duration of the flight with cloud-based, real-time data analysis and collection, designed to ensure safe and effective delivery.

“While more remains to be done to operationalize medical cargo drones in distress, successful tests like this one demonstrate that remarkable new humanitarian capabilities are emerging quickly,” said Schroeder.

Volans-i built and operated the all-electric drones. Softbox developed the temperature-controlled payload box, which was connected by AT&T. Merck initiated the idea and provided supply chain expertise.

“This successful pilot demonstrates the potential of innovative UAV technology to aid in the delivery of temperature-dependent pills and vaccines to people who critically need them,” said Craig Kennedy, senior vice president of supply chain at Merck. “The potential of UAV technology is just one of the many areas in which we are innovating across our business and our supply chain to maximize our ability to save and improve lives around the world.”

The pilot in the Bahamas was the fourth in a series of proof-of-concept missions the group has undertaken to demonstrate the potential of delivering temperature-controlled medicines and vaccines using drones.

“Our goal is to revolutionize the way goods and people move in the world,” said Hannan Parvizian, CEO and co-founder of Volans-i. “demonstrating our ability to make temperature-controlled drone deliveries in various climate and terrain conditions across these pilots is a first step towards realizing our vision for a world in which no one should be deprived of access to life-saving medical supplies and vaccination due to lack of infrastructure and responsiveness of the transportation ecosystem.”

The group previously launched test flights in Switzerland and Puerto Rico.

“The data collected during the successful flights have shown everybody involved the power of IoT to provide full visibility of the cold chain, even in the most extreme environments while using innovative transportation modes,” said Richard Wood, director of digital connected Technologies at Softbox.

The organizations involved in the successful pilot plan to continue to explore ways in which this technology can be used to deliver life-saving medicines and vaccines to the communities that need them most.

“Through close collaboration with Direct Relief, Merck, Volans-I and AT&T, we have successfully proven the capabilities of this unique and ground-breaking combination of cutting-edge technologies and now will focus our efforts on completing subsequent pilot projects,” said Wood.

Filed Under: , , , , ,

Giving is Good Medicine

You don't have to donate. That's why it's so extraordinary if you do.